Objectives: Canine atrial cardiomyocytes display a constitutively active, acetylcholine-regulated, time-dependent K + current (I KH ) that contributes to atrial repolarization and atrial tachycardia-induced atrial-fibrillation promotion. Adrenergic stimulation favors atrial arrhythmogenesis but its effects on I KH are poorly understood. Methods and results: Adrenergic modulation of I KH was studied in isolated canine atrial cardiomyocytes with whole-cell patch-clamping, and action-potential consequences were assessed in multicellular preparations with fine-tipped microelectrodes. Isoproterenol increased I KH in a concentration-dependent manner (maximum 103 ± 22% increase), an effect mimicked by forskolin and 8-bromo-cyclic AMP. Isoproterenol effects were prevented by propranolol and the selective β 1 -adrenoceptor blocker CGP-20712A, but not the β 2 -blocker ICI-118551. Isoproterenol enhancement was prevented by pipette-administered protein kinase A (PKA) inhibitor peptide or by superfusion of H89 (PKA blocker). Phenylephrine decreased I KH in a reversible, concentration-dependent way. This effect was blocked by the α-antagonist prazosin and the selective α 1A -blocker niguldipine, but not the α 1B -blocker chloroethylclonidine or the α 1D inhibitor BMY-7378. Phenylephrine effects were prevented by the phospholipase C (PLC) inhibitor U73122 and the protein kinase C (PKC) inhibitor bisindolylmaleimide. The PKC-activating phorbol ester PDD (but not its inactive analogue α-PDD) mimicked phenylephrine effects. Action potential recordings in the presence and absence of the selective I KH blocker tertiapin indicated a functional role of α-and β-adrenergic actions on I KH . Adrenergic regulation of cholinergic agonist-induced K + current paralleled that of I KH . Conclusions: I KH is under dual regulation by the adrenergic system: β 1 -adrenergic stimulation enhances I KH via cAMP-dependent PKA pathways, whereas α 1A -adrenergic stimulation inhibits I KH via PLC-mediated PKC activation. Modulation of constitutive acetylcholineregulated K + current is a novel potential mechanism for adrenergic control of atrial repolarization.
Introduction
We recently characterized a hyperpolarization-activated, time-dependent constitutively active acetylcholine-regulated K + current in canine atrial cardiomyocytes, named I KH because of characteristic time-dependent activation on hyperpolarization [1] . I KH is sensitive to a highly selective Kir3 current blocker, tertiapin-Q [1] . Atrial tachycardiainduced remodeling increases I KH , which plays a significant role in remodeling-associated atrial fibrillation (AF) promotion and action potential (AP) duration (APD) abbreviation [2] . A corresponding constitutive acetylcholine-regulated, tertiapin-Q sensitive current is up-regulated in atrial cardiomyocytes from AF patients [3] . Adrenergic stimulation is an important regulator of cardiac ion-channel function [4, 5] and arrhythmias [6, 7] . We previously found I KH to be enhanced by β-adrenoceptor stimulation [1] , but underlying receptor-subtype and signal-transduction systems were not probed, nor was functional importance studied. In addition, the α-adrenergic modulation of I KH is unexplored. The present study assessed the adrenergic regulation of I KH with respect to receptor-subtypes, signal-transduction pathways and role in mediating effects on atrial repolarization.
Materials and methods

Tissue and cell preparations
All animal-care procedures were consistent with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) . Adult mongrel dogs of either sex (19-38 kg) were anaesthetised with pentobarbital (30 mg/kg I.V.) and artificially ventilated with room air. Hearts were excised through a left lateral thoracotomy and immersed in oxygenated Tyrode solution. A left atrial (LA) preparation was dissected and perfused at ∼ 10 mL/min via the left circumflex coronary artery, for either cardiomyocyte isolation with previously detailed methods [1, 2] or AP recording.
Electrophysiology
Currents were recorded with whole-cell patch-clamp techniques at 36 ± 0.5°C as previously described [1, 2] . Borosilicate-glass electrodes (tip resistances 1.5-3.0 MΩ) were used to record whole-cell currents. Junction potentials were zeroed prior to formation of gigohm seals. Compensated series-resistances and capacitive time-constants averaged 3.4 ± 0.2 MΩ and 286 ± 88 μs, respectively. Cellcapacitances averaged 94 ± 6 pF. Original recordings are presented in terms of current amplitude, but mean data are shown as current-density (pA/pF). Currents were recorded with hyperpolarizing and depolarizing pulses from a holding potential (HP) of − 40 mV. I KH was quantified [1, 2] as the time-dependent current elicited under conditions designed to minimize other potential current contributions.
AP-recordings were obtained with fine-tipped standard borosilicate-glass microelectrodes in intact multicellular coronary artery-perfused LA preparations [1, 2] . Floating microelectrodes (resistances 10-20 MΩ when filled with 3 mol/L KCl) connected to a high-input impedance amplifier were used to record APs at 2 Hz in the presence and absence of adrenergic agonists and tertiapin-Q.
Solutions
Tyrode solution contained (mmol/L): NaCl 136, KCl 5.4, MgCl 2 Stock solutions of isoproterenol (1 mmol/L) were prepared under protection from light on the day of experiments and freshly-prepared ascorbic acid (100 μmol/L) was added to prevent oxidization. Tertiapin-Q was dissolved in 0.1% acetic acid. Unless otherwise specified, chemicals were obtained from Sigma.
Data analysis
Clampfit 6.0 (Axon) and GraphPad Prism 3.0 were used for data analysis. Group data are presented as mean ± SEM. Two-way ANOVA and Bonferroni post-hoc tests were used for statistical comparisons, with an interaction variance analysis to determine the statistical significance of isoproterenol-tertiapin and phenylephrine-tertiapin interaction effects on APD. P values b 0.05 were considered statistically significant.
Results
Effects of isoproterenol on I KH
Fig . 1A and B shows typical I KH recordings from one cell at baseline and after isoproterenol (1 μmol/L). Isoproterenol increased currents both during voltage-steps and upon repolarization. Fig. 1C shows the response of the same cell to propranolol (1 μmol/L) in the continued presence of isoproterenol. Mean time-dependent I KH density-voltage relations before and after isoproterenol are shown in Fig. 1D . Isoproterenol significantly increased I KH . The effects of isoproterenol were concentration-dependent ( Fig. 1E ): I KH density at − 120 mV was increased 26 ± 3.8% by 0.01 μmol/L, 78 ± 19% by 0.1 μmol/L, and 103 ± 22% by 1 μmol/L isoproterenol. Isoproterenol effects were reversed by propranolol, e.g. I KH at − 120 mV increased with isoproterenol from − 1.53 ± 0.12 to − 3.05 ± 0.59 pA/pF, and returned to − 1.69 ± 0.18 pA/pF (n = 6) with the addition of propranolol. Washout reversed the effects of the drug. Ascorbic acid alone did not affect the current.
To evaluate the β-adrenergic receptor subtype involved, we applied selective β-adrenergic receptor blockers along with 1 μmol/L isoproterenol: CGP-20712A methanesulfonate (CGP, 300 nmol/L, β 1 -selective) and ICI-118,551 hydrochloride (ICI, 50 nmol/L, β 2 -selective). The β 1 -receptor blocker CGP fully prevented isoproterenol-enhancement of I KH , whereas the β 2 -receptor blocker ICI failed to alter isoproterenol's action (Fig. 2, top) .
Effects of forskolin and 8-bromo-cyclic AMP
To evaluate the role of cyclic AMP (cAMP), studies were performed with forskolin, which activates adenylyl cyclase independently of β-adrenergic receptors, and 8-bromo-cAMP, a membrane-permeable form of cAMP. Both compounds significantly enhanced I KH (Fig. 2, bottom) . For example, forskolin increased I KH density at −120 mV from −4.1 ± 0.3 to −8.1 ± 0.7 pA/pF. At the same voltage, 8-bromo-cAMP increased I KH from −3.3 ± 0.5 to −4.8 ± 0.7 pA/pF. The effects of both compounds were reversible upon washout. These results indicate that the enhancement of I KH induced by β-adrenergic stimulation is due to increases in intracellular cAMP concentrations.
Role of protein kinase A
To determine the role of cAMP-dependent protein kinase A (PKA), we first used the protein kinase A inhibitor H89 (10 μmol/L). To study isoproterenol effects in the presence and absence of H89 in the same cell, we assessed two 10-minute isoproterenol (1 μmol/L) exposures in each cell, one without and the other with simultaneous superfusion of H89. Parallel experiments were performed in an identical fashion, but without H89 during the second isoproterenol exposure, to assess the reproducibility of isoproterenol's effect. Mean results are shown in Fig. 3A and B. Repeated isoproterenol exposure in the absence of H89 enhanced I KH during each exposure, but H89 fully prevented isoproterenol's action.
We used H89 because it allows for control exposures in the same cell. However, H89 can have complex inhibitory interactions with β-adrenoceptors [8] . We performed additional experiments with a specific intracellular PKA inhibitor peptide (PKI). I KH was recorded at − 120 mV immediately after rupture, then after 20 min of dialysis with a pipette solution containing 50 nmol/L PKI. I KH was unaffected by pipette application of PKI, averaging 2.3 ± 0.7 pA/pF immediately upon cell rupture and 2.3 ± 0.6 pA/pF after PKI dialysis in 6 cells (at −120 mV). Isoproterenol (1 μmol/L) application failed to affect I KH in the presence of intracellular PKI: in 6 cells, I KH density averaged 2.3 ± 0.7 pA/pF before, versus 2.6 ± 0.6 pA/pF after, isoproterenol exposure (P =NS).
Alpha-adrenergic effects on I KH
To study α-adrenergic effects on I KH , phenylephrine was infused in the presence of 1 μmol/L propranolol to block any potential collateral β-adrenergic stimulation. Fig. 4A and B shows representative recordings before and after 1 mmol/L phenylephrine. Both time-dependent activating and tail current were reduced. Mean I KH density-voltage relations before and after phenylephrine are shown as a function of step potential in Fig. 4C . Panel D shows the concentrationdependent inhibitory effect of phenylephrine on I KH at − 120 mV: I KH was decreased 23.1 ± 3.7% by 10 μmol/L, 36.5 ± 5.4% by 100 μmol/L, and 47.0 ± 3.8% by 1 mmol/L phenylephrine. The inhibitory effect was reversible upon drug washout (data not shown). The effect of phenylephrine (1 mmol/L) was completely prevented upon co-administration with the α 1 -adrenoceptor inhibitor prazosin (2 μmol/L).
To evaluate the α 1 -adrenergic receptor subtype involved, selective α 1 -adrenergic receptor blockers, niguldipine (Nig, 10 nmol/L, α 1A -selective), chloroethylclonidine (CEC, 10 μmol/L, α 1B -selective) or BMY-7378 (BMY, 1 nmol/L, α 1D -selective), were applied together with 1 mmol/L phenylephrine (in the presence of 1 μmol/L propranolol). The α 1A -antagonist niguldipine fully prevented phenylephrine-induced suppression of I KH (Fig. 4E) , whereas the α 1B and α 1D -receptor blockers CEC (Fig. 4F) and BMY ( Fig. 4G ) did not. leading to protein kinase C (PKC) activation. When cardiomyocytes were pre-treated with the PLC inhibitor, U73122 (1 μmol/L), the addition of phenylephrine (1 mmol/ L) failed to suppress I KH (Fig. 4D, right) . The potential role of PKC was then evaluated with the protein kinase C-activating phorbol ester, phorbol-12,13-didecanoate (PDD). PDD substantially reduced both activating and tail current I KH components. Mean activating current density-voltage relations before and after PDD are shown in Fig. 3C . Overall, 100 nmol/L PDD decreased I KH at − 120 mV by 52 ± 6%. The non-PKC-activating PDD congener 4α-PDD had no effect on I KH -e.g., at − 120 mV I KH averaged 1.5 ± 0.2 pA/pF before, versus 1.6 ± 0.4 pA/pF after, 100 nmol/L α-PDD superfusion (n = 5 cells, P = NS).
We then assessed the ability of the highly-selective PKC inhibitor bisindolylmaleimide-I (50 nmol/L), to prevent the inhibitory action of phenylephrine. Cells were pre-treated with bisindolylmaleimide for 10 min and phenylephrine (1 mmol/L) was then added along with bisindolylmaleimide. In the presence of bisindolylmaleimide, phenylephrine failed to alter I KH (Fig. 3D) . I KH density (at − 120 mV) averaged 2.2 ± 0.4 pA/pF before, and 2.1 ± 0.4 pA/pF after, bisindolylmaleimide (n = 5 cells, P = NS). The PDD and bisindolylmaleimide results confirm the role of PKC.
Role of isoproterenol and phenylephrine effects on I KH in AP repolarization
To assess the functional role of adrenergic modulation of I KH , we tested the effects on left atrial action-potential (AP) duration (APD) of suppressing I KH with the highly selective blocker tertiapin-Q (TQ, 100 nmol/L). If adrenergic effects on I KH contribute to changes in repolarization, the result of I KH inhibition should be increased in the presence of β-adrenergic stimulation (which increases I KH ) and decreased in the presence of α-adrenergic stimulation (which reduces I KH ). Coronary-perfused multicellular preparations studied with standard fine-tipped microelectrodes were used to obtain as physiological conditions as possible. Tissue preparations were subjected to AP recordings from multiple cells under baseline conditions and then at steady state after perfusion with (1) tertiapin-Q alone (n = 4 dogs), (2) isoproterenol alone (n = 6 dogs), (3) isoproterenol plus tertiapin-Q (n = 5 dogs), (4) phenylephrine alone (n = 4 dogs) or (5) phenylephrine plus tertiapin-Q (n = 4 dogs).
Fig. 5A-C shows representative left atrial APs under the various conditions studied. Tertiapin alone prolonged APD to 90% repolarization (APD 90 ) by 22%. In the presence of isoproterenol, tertiapin increased APD 90 by 72% (values in the presence of both isoproterenol and tertiapin compared to values with isoproterenol alone). In the presence of phenylephrine tertiapin increased APD 90 by only 10% (values in presence of phenylephrine and tertiapin compared to values with phenylephrine alone). These results indicate that isoproterenol-enhancement of I KH results in a larger APD-prolonging effect of I KH -inhibition by tertiapin, whereas phenylephrine-induced I KH suppression attenuates tertiapin-Q's ability to prolong APD. The results of an analysis of the statistical significance of the interaction between the effects of isoproterenol or phenylephrine and tertiapin (based on raw data, not percentage changes) are shown in Table 1 . There were statistically significant interactions between the effects of tertiapin-Q and isoproterenol and between tertiapin-Q and phenylephrine, (Fig. 6A) . I K1 was not changed by isoproterenol but was significantly reduced by phenylephrine. Neither isoproterenol nor phenylephrine significantly changed outward I K1 , suggesting that I K1 contributes little to APD-changes induced by adrenergic stimulation.
I KACh was induced by 500 nmol/L carbachol (Fig. 6B ). Consecutive carbachol exposures were performed in each cell, first without and then with simultaneous superfusion of 100 nmol/L isoproterenol or 100 μmol/L phenylephrine (along with 1 μmol/L propranolol). The effect of carbachol washed out following carbachol exposures. I KACh was significantly increased by isoproterenol (n = 5 cells, P b 0.05) but was significantly decreased by phenylephrine (n = 5 cells, P b 0.05). Repeated carbachol exposure without adrenergic agonists reproducibly activated I KACh of the same amplitude (n = 4 cells).
Discussion
In the present study, we demonstrated that β 1 -and α 1A -adrenergic receptor systems modulate I KH . The currentenhancing effects of β 1 -adrenergic stimulation are mediated by cyclic AMP-induced activation of PKA, whereas the inhibitory effects of α 1A -adrenergic stimulation proceed by PLC-mediated activation of PKC. The adrenergic modulation of I KH contributes to changes in repolarization.
Relationship to previous studies of adrenergic actions on K + -channels
Adrenergic modulation is well-known to modulate the properties of K + -channels. β-Adrenergic stimulation via a cAMP-dependent PKA mechanism enhances a variety of cardiac K + currents including I K , in particular the slow component I Ks [9] [10] [11] and I Kur [12] , but has been reported to inhibit I K1 [13, 14] . We did not observe significant β-adrenergic effects on I K1 in the present study. α-Adrenergic stimulation inhibits several K + currents, including I to [15, 16] and I K1 [ [17, 18] and present study], but enhances delayed-rectifier K + currents in guinea pig ventricle [19] . α-Adrenergic stimulation decreases I Kur in human atrial cardiomyocytes [12] but enhances the corresponding current in canine atrial myocytes [20] .
In both rat atrial myocytes and Xenopus oocytes, β-adrenergic stimulation enhances acetylcholine-evoked Kir3-based currents (I KACh ) via cAMP-dependent protein kinase [21] . In Xenopus oocytes injected with Kir3.1/Kir3.4 subunits, M 2 -cholinergic and β-adrenergic receptors, isoproterenol elicited Kir3.1/3.4 currents even in the absence of acetylcholine [21] , a result analogous to our observation of β-adrenergic enhancement of I KH in the absence of muscarinic agonists. Phenylephrine accelerates the decay of I KACh via depletion of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) in mouse atrial cardiomyocytes [22] . In rabbit atrial cardiomyocytes, α-adrenergic stimulation also reduces I KACh [18] . On the other hand, α-adrenergic stimulation activates I KACh via 5′-lipoxygenase or metabolites of arachidonic acid in guinea pigs [23] . These observations indicate the potential diversity of α-adrenergic effects on Kir 3-related currents. The present study is the first to show that adrenergic stimulation modulates constitutive Kir3-related currents in mammalian atrial cardiomyocytes. We also noted β-adrenergic enhancement and α-adrenergic suppression of agonistinduced I KACh , suggesting congruent adrenergic regulation of both constitutive and agonist-induced Kir3 currents in canine atrial cardiomyocytes. Because adrenergic stimulation affects a large number of currents involved in cardiac repolarization [4, 5] , it is challenging to determine whether adrenergic effects on one specific current play a functional role. In this study, we addressed the functional significance of adrenergic regulation of I KH by observing the effect of blocking the current with a highly selective inhibitor, tertiapin-Q, in the absence of adrenergic stimulation and then in the presence of α-or β-adrenoceptor agonists.
Mechanisms of adrenergic modulation of I KH
Protein kinases are important components of the signal transduction system for adrenergic stimulation. β-Adrenergic stimulation enhances inward-rectifier K + currents in glial cells [24] and acetylcholine-activated currents in rat atrial cardiomyocytes [25] , with substantial evidence for a central role of PKA-phosphorylation in mediating such actions [21, [24] [25] [26] [27] . Stimulation of α-adrenergic receptors leads to various biochemical responses, including enhanced Ca 2+ influx, PLC activation, and changes in intracellular cyclic nucleotide levels. The activation of PLC results in PIP 2 hydrolysis and activation of PKC. PIP 2 depletion has been shown to inhibit Kir3.x-related currents [28, 29] . PKC is also frequently implicated as an inhibitor of Kir3-related currents [30] [31] [32] [33] [34] [35] , with specific serine phosphorylation sites in Kir3.1 and 3.4 being essential for PKC-dependent inhibition of GIRK channels [35] . In atrial cardiomyocytes, Kir3 channels are assembled in a signalling complex along with Gβ γ , G protein-coupled receptor kinase, cyclic adenosine monophosphate-dependent protein kinase, and receptor for activated C kinase 1 (RACK1) [33] . Other recent studies have demonstrated that these signalling complexes may be formed during biosynthesis [36, 37] , and provide a basis for distinct signalling arrays in different cell types (for review, see Ref. [38] ). It is clear that cellular context is a key feature of how signal integrators such as Kir3 channels are regulated. All of the modulatory effects on I KH were mediated by protein kinases, with no evidence for protein-kinase independent direct membrane-delimited mechanisms. Receptor-mediated inhibition of Kir3 related currents may occur independently of PKC activation [18, 22, 29, 39] . Complicated interactions between PLC-induced PKC activation and PIP 2 depletion may lead to varying consequences. In rabbit atrial myocytes, reductions in membrane PIP 2 content prevent Kir3 channel-PIP 2 interactions and decrease corresponding currents [40] . PKC-dependent phosphorylation of phosphatidylinositol transfer protein can reduce membrane PIP 2 content [41] . In our studies, PKC inhibition prevented the inhibitory effect of phenylephrine on I KH , suggesting that in canine atrial cardiomyocytes PKC activation plays a primary role in mediating α-adrenergic inhibition of the Kir3-based current I KH .
Potential physiological and clinical relevance
Adrenergic stimulation plays a role in governing atrial APD and refractoriness. Both α-and β-adrenergic stimulation modulates various ion channels and therefore exerts potentially complex effects on APD [4, 5, 42] . Diverse effects of adrenergic stimulation on APD in different tissues and species have been reported [43, 44] . In our study, β-adrenergic stimulation abbreviated canine atrial APD markedly, whereas α 1 -adrenergic stimulation tended to prolong APD slightly. Our studies of the AP response to tertiapin-Q under varying adrenergic-stimulation conditions (Fig. 5, Table) indicate functional significance for isoproterenol's effects on I KH and suggest that they contribute to β-adrenergic APD shortening. The small, statistically non-significant net effect of α 1 -adrenoceptor stimulation on APD suggests that the APD prolongation that would result from I KH inhibition is offset by α-adrenoceptor actions on other currents.
The autonomic nervous system is known to contribute to arrhythmogenesis [6, 7] . We previously showed that I KH block by tertiapin-Q suppresses both APD-shortening and arrhythmia-promoting effects of atrial tachycardia remodeling, pointing to a significant role of I KH in atrial arrhythmogenesis [2] . Patients with AF have enhanced constitutive I KACh analogous to I KH [3] . In addition, I KACh single channel events compatible with I KH have been observed in the absence of cholinergic agonists in human atrial cardiomyocytes [45, 46] . The present observations point to the potential role of constitutive acetylcholineregulated current as a mediator of adrenergic effects on atrial APD and arrhythmias. β-Adrenoceptor blocking drugs can prevent AF [47] . β-Adrenergic modulation of constitutive acetylcholine-regulated K + current may contribute to this action. The importance of interactions between the results of cholinergic and adrenergic stimulation on the heart is well established [48, 49] . The present study provides evidence for the functional importance of a novel mechanism of cardiac adrenergic-cholinergic system interactions: adrenergic modulation of acetylcholine-regulated currents that are active in the absence of cholinergic agonists. 
Potential limitations
We relied heavily on pharmacological tools for dissection of protein kinase systems, so specificity is always a potential issue. Bisindolylmaleimide is a highly selective inhibitor of PKC [50] . H89 inhibits PKA without effects on PKC, although it can exert effects on other kinases [51] and can directly inhibit β-adrenoceptors [8] . We therefore performed complementary experiments in which PKI peptide was used as a specific inhibitor of PKA [52] . We nevertheless show both sets of data, because since H89 is given by extracellular superfusion results can be obtained before and after the drug in the same cell, whereas the adrenergic response cannot be examined in the same cell before and after administration of PKI (which is dialyzed intracellularly). Tertiapin-Q was a key tool in studies of the functional significance of adrenergic regulation of I KH . Drici et al. have shown that tertiapin, at concentrations that strongly suppress I KACh , has no effect on I Kr , I Ks , I to , I Kl , I Na , or I CaL [53] . In addition, we verified that under the conditions in this study there was no detectible "funny" current (I f ) before or after isoproterenol (data not shown).
In the present study, we assessed adrenergic regulation of the constitutive Kir3-based current I KH . We also noted α-adrenergic modulation of I K1 and α -and β-adrenergic modulation of agonist-induced I KACh , which could contribute to in-vivo APD-regulation. However, the role of I KH in APD-regulation that we observed with the use of tertiapin (Table, Fig. 5 ) is unlikely to be contaminated by effects on I K1 because I K1 is tertiapin-insensitive, nor by effects on agonist-induced I KACh because these experiments were performed in the presence of the muscarinic-receptor blocker atropine.
